Han JH, Cho SR. An old misconception: Dutcher bodies are intranuclear inclusions in plasma cells? Leuk Lymphoma 60(1):265-67, 2019
Choi YW, Park JS, Han JH, Kim JH, Ahn MS, Lee HW, Kang SY, Choi JH, Jeong SH. Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma. Leuk Lymphoma 59(11):2670-78, 2018
Kim SY, Kim HJ, Kim HJ, Kim DH, Kim CH, Han JH, Byeon HK, Lee K. HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer. Autophagy. 14(3):385-403, 2018
Choi YW, Jeon SY, Jeong GS, Lee HW, Jeong SH, Kang SY, Park JS, Choi JH, Koh YW, Han JH, Sheen SS. EGFR exon 19 deletion is associated with favorable overall survival after first-line Gefitinib therapy in advanced non-small cell lung cancer. Am J Clin Oncol. 41;385-390, 2018
Koh YW, Han JH, Yoon DH, Suh C, Hur J. Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin’s lymphoma. Hematol Oncol. 36:182-188, 2018
Koh YW, Han JH, Yoon DH, Suh C, Hur J. PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma. Ann Hematol. 96(11);1883-1890, 2017
Han JH, Kim HA. Serum levels of interleukin-33 and soluble ST2 are associated with extent of disease activity and cutaneous manifestations in patients with active adult-onset Still’s disease. J Rheumatol. 44(6):740-747, 2017
Han JH, Suh CH, Jung JY, Ahn MH, Han MH, Kwon JE, Yim H, Kim HA. Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still’s disease. Sci Rep. 24;7:46652, 2017
Koh YW, Han JH, Park SY, Yoon DH, Suh C, Huh J. GLUT1 as a Prognostic Factor for Classical Hodgkin’s Lymphoma: Correlation with PD-L1 and PD-L2 Expression. J Pathol Transl Med. 51(2):152-158, 2017
Han JH. The pathological diagnosis and interpretation of pathologic results: Emphasis on immunohistochemical staining. Korean J Med.92;36-40, 2017
Kim HA, Han JH, Kim WJ, Noh HJ, An JM, Yim H, Jung JY, Kim YS, Suh CH. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations. Int J Mol Sci . 16;17(8), 2016
Kim M, Han JH, Kim JH, Park TJ, Kang HY. Secreted Frizzled-related protein 2 (sFRP2) functions as a melanogenic stimulator; the role of sFRP2 in UV-induced hyperpigmentary disorders. J investigative Dermatol. 136;236-44, 2016
Han JH, Suh CH, Jung JY, Nam YJ, Kwon JE, Yim H, Kim HA. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still’s disease. Arthritis Res and Ther. 17;260, 2015
Jeon YK, Kim JH, Sung JY, Han JH, Ko YH. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. Hum Pathol. 46;981-990, 2015
Kim HA, Kwon JE, Yim H, Suh CH, Jung JY, Han JH. The pathologic findings of skin, lymph node, liver and bone marrow in patients with adult-onset Still’s disease: A comprehensive analysis of 40 cases. Medicine. 94;e787,2015
Yoon S, Park SJ, Han JH, Kang JH, Kim J, Lee J, Park S, Shin H, Kim K, Yun M, Chwae YJ. Caspase-dependent cell death associated release of nucleosome and damage-associated molecular patterns. Cell Death Dis. 5;e1494, 2014
Park JH, Han JH, Kang HY, Lee ES, Kim YC. Expression of follicular helper T-cell markers in primary cutaneous T-cell lymphoma. Am J Dermatopathol 36:465-470, 2014
Han JH, Ko YH, Kang YK, Kim WS, Kim YJ, Kim I, Kim HJ, Min SK, Park CK, Park CS, Shin BK, Yang WI, Oh YH, Lee JS, Lee J, Lee TH, Lee H, Lee HJ, Jeon YK, Cha HJ, Choi YD, Kim CW, Hematopathology Study Group of the Korean Society of Pathologists. Characteristics of cutaneous lymphomas in Korea according to the new WHO-EORTC classification: Report of a Nationwide study. Korean J Pathol 48:126-132, 2014
Park JH, Han JH, Kim YC. Epstein-barr virus-positive primary cutaneous diffuse large B-cell lymphoma in an immunocompetent patient. Ann Dermatol 26:119-121, 2014